MEK inhibitor alone induced robust apoptosis but failed to engage the cell cycle checkpoint; CDK4/6 inhibitor treatment alone suppressed proliferation but failed to impact on apoptosis, and the combination of MEK and CDK4/6 inhibitors resulted in both apoptosis and cell cycle arrest in the xenograft of NRASQ61K mutation melanoma [273]. Here, MAP2K7 is linked to melanoma.